NEW YORK (Reuters Health) – In premenopausal women with breast cancer, adjuvant tamoxifen treatment significantly reduces the risk of contralateral breast cancer, according to results of a Swedish study.
“This is to our knowledge the first data…from a controlled randomized trial” to show this...